Sonendo, Inc. · OTC:SONX
Sonendo — Investor Presentation (January 2022)
21 slides from Sonendo's investor presentation, Jan 10, 2022
Slide 1: Sonendo: Saving Teeth Through Sound Science
“Be Z SONENDO SAVING TEETH THROUGH SOUND SCIENCE January 2022
Slide 2: Disclaimer and Confidentiality Notice
Disclaimer and Confidentiality Notice This presentation contains forward-looking statements with respect to the Company. These forward-looking statements, by their nature, require the Company to make certain assumptions and necessarily involve known and unknown risks and uncertainties that could cau
Slide 3: Our Mission
Our Mission Improve Quality of Life by Saving Teeth and Stopping the Progression of Tooth Decay Establish the GentleWave Procedure as the Standard of Care for Tooth Decay, with an Initial Focus on Transforming Root Canal Therapy
Slide 4: Strong and Experienced Leadership Team
Strong and Experienced Leadership Team Introducing the Team Bjarne Bergheim President & CEO Michael Watts Chief Financial Officer Michael Smith Chief Commercial Officer Mehrzad Khakpour, PhD Chief Technology Officer Jacqueline Collins VP, General Counsel Andrew Kirkpatrick Chief Operating Officer Ro
Slide 5: Key Success Factors for Sonendo
Key Success Factors for Sonendo Paradigm-Shifting Platform Technology for Tooth Decay Compelling and Growing Body of Clinical and Real-World Evidence Established and Growing Digital Infrastructure Recurring Revenue Business Model Large Market Opportunity with Significant Need for Innovation Transfor
Slide 6: Large Market For Root Canal Therapy
~17 Million Root Canal Procedures Performed Annually in the U.S. and Canada Large Market For Root Canal Therapy (RCT) Non-Referring General Practitioners (GPs) (~50,000) ~9 million Annual Root Canal Procedures Remaining General Practitioners (GPs) (~126,000) ~4 million Annual Root Canal Procedures E
Slide 7: The Root Canal System is Complex
The Root Canal System is Complex Endodontic Biofilm Root Canal Dentin Dentin Root Canals are Complex… …Making Them Difficult to Effectively and Efficiently Clean Bacteria are smaller than anatomical features in the tooth Canals are increasingly complicated in hardest to reach areas Bacteria penetrat
Slide 8: Limitations of Conventional RCT
Limitations of Conventional RCT Ng YL. et al. Outcome of primary root canal treatment: systematic review of the literature - part 1. Effects of study characteristics on probability of success. Int Endod J. 2007; 40(12):921-39. POOR CLINICAL OUTCOMES RCT treatment failure ranges from 15% to 32%1 29%
Slide 9: GentleWave System: Transforming RCT
First and only FDA-cleared system for RCT that employs a sterilized, single-use procedure instrument to automate the cleaning of root canals Superior cleaning and disinfection of microscopic spaces independent of root canal complexity and tooth structure Intuitive touchscreen interface simplifies pr
Slide 10: GentleWave Procedure vs Conventional RCT
vs GentleWave Procedure Conventional RCT GentleWave Procedure Enables Superior Cleaning 10
Slide 11: Clinical and Commercial Validation of the GentleWave Procedure
In-Vivo and In-Vitro in… In Real-World, Clinical Practice, with… 2 Prospective, Multi-Center Clinical Studies 30+ Peer-Reviewed Journal Publications ~820 GentleWave System Installed Base Clinical and Commercial Validation of the GentleWave Procedure The Clinical Benefits of the GentleWave System Hav
Slide 12: PURE Study: Strong Clinical Outcomes
1 PURE Study: Single-Arm, Multi-Center, Prospective, Non-Significant Risk Clinical Study Strong Clinical Outcomes Note: Data for GentleWave and conventional RCT is from separate studies. Clinical data is not head-to-head. Ng YL. et al. Outcome of primary root canal treatment: systematic review of th
Slide 13: Proven, Real-World Results Supported by Clinical Studies
Proven, Real-World Results Supported by Clinical Studies and Commercial Experience Enhanced Procedure Efficiency Clinical Study Results Patients Treated in a Single Visit Using the GentleWave System2 Patients with Periapical Lesions Treated in a Single Visit Using the GentleWave System3 GentleWave P
Slide 14: Establishing the GentleWave Procedure as the Standard of Care for RCT
Establishing the GentleWave Procedure as the Standard of Care for RCT U.S. and Canada Commercial Strategy How? 1 Grow GentleWave Installed Base 2 Increase GentleWave Procedure Utilization 3 Drive Patients to GentleWave Providers Increase Referrals Targeted Direct-to-Patient Marketing Increase Awaren
Slide 15: How We Structure Our Sales Team
How We Structure Our Sales Team CAPITAL SALES REP Increase Market Penetration CONSUMABLE SALES REP Drive Account Utilization KEY RESPONSIBILITIES Win new business Establish customer relationships Target key opportunities Focus on GentleWave Console placements Grow installed base of GentleWave Consol
Slide 16: CleanFlow PI: Our Next Generation Procedure Instrument
CleanFlow PI Our Next Generation Procedure Instrument TM
Slide 17: CleanFlow Procedure Instrument: Driving Procedure Simplicity
CleanFlow Procedure Instrument: Driving Procedure Simplicity No components placed inside tooth Simplified & Intuitive Value for Sonendo Commercial Status Cleans inside of tooth from outside Reduces procedure steps Easier and less technique-sensitive Confidence to use on more cases Fewer parts and ea
Slide 18: Our Key Growth Strategies
Our Key Growth Strategies Focused on Driving Long-Term, Sustainable Growth Strategy Key Elements Execute U.S. and Canada Commercial Strategy Reduce Costs and Improve Production Efficiencies Invest in R&D Initiatives Expand into International Markets Expand sales and marketing teams Grow installed ba
Slide 19: 2021 Financial Highlights
2021 Financial Highlights $33.0 to $33.2million Full Year 2021 Estimate ~820 Consoles Placed Revenue Installed Base Sales Territories 24 (Covering US and Canada) We had 16 capital sales reps at the end of Q2’21
Slide 20: Key Success Factors for Sonendo
Key Success Factors for Sonendo Paradigm-Shifting Platform Technology for Tooth Decay Compelling and Growing Body of Clinical and Real-World Evidence Established and Growing Digital Infrastructure Recurring Revenue Business Model Large Market Opportunity with Significant Need for Innovation Transfor
Slide 21: Thank you
rm o z w rs) a fal z =) ° a x © Thank you 'e] a z UE 2. 0 Wi: y “Be